I’m not following your maths? They are forecasting not far off a breakeven last seven months of the financial year and growing FUM and revenue aggressively with cash at bank and revenue growth to likely be amplified by the removal of the uncertainty on the suspension. More cost savings due to not being in default on the con note. This has been a dog of a stock for too long, but credit to the new leadership where it's due, they have come a long way in a short period. An inflection point IMO. DYOR.
- Forums
- ASX - By Stock
- Ann: Pre-Quotation Disclosure and Business Update
I’m not following your maths? They are forecasting not far off a...
Featured News
Add DCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.790M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DCL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online